Strides Pharma Science (NSE:STAR) EV-to-Revenue : 2.51 (As of Jun. 07, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Strides Pharma Science's enterprise value is ₹101,859 Mil. Strides Pharma Science's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹40,511 Mil. Therefore, Strides Pharma Science's EV-to-Revenue for today is 2.51.

The historical rank and industry rank for Strides Pharma Science's EV-to-Revenue or its related term are showing as below:

NSE:STAR' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.71 Med: 2.42 Max: 19.72
Current: 2.51

During the past 13 years, the highest EV-to-Revenue of Strides Pharma Science was 19.72. The lowest was 0.71. And the median was 2.42.

NSE:STAR's EV-to-Revenue is ranked worse than
54.02% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.255 vs NSE:STAR: 2.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-07), Strides Pharma Science's stock price is ₹879.65. Strides Pharma Science's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹445.11. Therefore, Strides Pharma Science's PS Ratio for today is 1.98.

Strides Pharma Science EV-to-Revenue Historical Data

The historical data trend for Strides Pharma Science's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science EV-to-Revenue Chart

Strides Pharma Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

1.82

2.98

1.98

1.41

2.29

Strides Pharma Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.41	1.06	1.82	1.51	2.29

Competitive Comparison of Strides Pharma Science's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strides Pharma Science's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's EV-to-Revenue falls into.

Strides Pharma Science EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Strides Pharma Science's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	101858.877	/	40511.24
	=	2.51

Strides Pharma Science's current Enterprise Value is ₹101,859 Mil.
Strides Pharma Science's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹40,511 Mil.

Strides Pharma Science (NSE:STAR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Strides Pharma Science's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	879.65	/	445.112
	=	1.98

Strides Pharma Science's share price for today is ₹879.65.
Strides Pharma Science's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹445.11.

Strides Pharma Science EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science (NSE:STAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » EV-to-Revenue

Traded in Other Exchanges

532531:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Strides Pharma Science (NSE:STAR) Headlines

No Headlines